Molecular imaging hack makes cameras 'faster'

18-Nov-2016 - A new Rice University technique grabs images of chemical processes that happen faster than most laboratory cameras are able to capture them. The technique, super temporal resolution microscopy (STReM), allows researchers to view and gather useful information about fluorescing molecules at a frame ...

Nanotube coating helps shrink mass spectrometers

27-Mar-2014 - Nanotechnology is advancing tools likened to Star Trek's "tricorder" that perform on-the-spot chemical analysis for a range of applications including medical testing, explosives detection and food safety. Researchers found that when paper used to collect a sample was coated with carbon nanotubes, ...

UCLA researchers create 'fly paper' to capture circulating cancer cells

New method may help improve diagnosis, prognosis and treatment monitoring

23-Nov-2009 - Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. These cells, known as circulating tumor cells, or CTCs, can provide critical information for ...

Nanoparticles light up tumors

Glowing 'Cornell dots' can show surgeons where tumors are

20-Feb-2009 - According to research at Memorial Sloan-Kettering Cancer Center (MSKCC), Cornell dots, also known as C dots, are biologically safe and stable and small enough to be easily transported across the body's structures and efficiently passed through the kidneys and out in urine. A single dot consists ...

Affimed joins the Molecular Imaging Technology Initiative

BMBF awards Affimed a funding grant of €550K

11-Feb-2009 - Affimed Therapeutics AG announced the start of a collaboration project with Bayer Schering Pharma AG, the German Cancer Research Center (DKFZ) and other partners within the Molecular Imaging Technology Initiative launched by the German Federal Ministry of Education and Research (“BMBF”). Affimed ...

Bruker Daltonik Receives ISO 13485 Certification for Development, Manufacturing and Distribution of Mass Spectrometry Systems

23-Apr-2008 - Bruker Daltonics announced that it has received EN ISO 13485 certification for its German operations. This ISO 13485 certification is an important milestone in the development of the Bruker Daltonics in vitro diagnostics (IVD) business, particularly in the fields of clinical proteomics, clinical ...

Biotage AB and McMaster University sign two year extension to Molecular Imaging Development Agreement

06-Mar-2008 - Biotage AB and McMaster University sign a two year extension to Molecular Imaging Development Agreement. McMaster University has successfully completed the first year research agreement, with a key journal publication and several technical presentations. "We used the Biotage Initiator Microwave ...

Affibody to start clinical development of a approach for the diagnosis of cancer

Swedish MPA gives go ahead for the clinical trial of Affibody's molecular imaging agent designed to improve the diagnosis of HER2-positive breast cancer.

28-Sep-2007 - Affibody Holding AB has received a letter from the Swedish Medical Product Agency (MPA) allowing it to begin an exploratory clinical trial of a new approach for diagnosing an aggressive form of breast cancer. The approach, which is based on the Company's lead proprietary targeting Affibody® ...

Biotage AB and McMaster University sign joint agreement to develop new chemistry platform

28-Feb-2007 - Biotage AB and McMaster University signed a joint agreement to develop a new chemistry platform to speed the production of molecular imaging and therapy agents. As part of the agreement, Biotage will provide funding and instruments. The McMaster Institute of Applied Radiation Sciences (McIARS) ...

Affibody AB provides novel molecular imaging agents for visualizing HER2-expressing cancer

09-May-2006 - Affibody AB announced that Cancer Research, the official publication of American Association of Cancer Research (AACR), has published an article by Affibody and collaborators on the development and evaluation of a new targeting molecule that can be used for visualization of HER2-expressing ...